Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial
Deciphera Pharmaceuticals, LLC
Sebastian Bauer; Robin L Jones; Jean-Yves Blay; Hans Gelderblom; Suzanne George; Patrick Schöffski; Margaret von Mehren; John R Zalcberg; Yoon-Koo Kang; Albiruni Abdul Razak; Jonathan Trent; Steven Attia; Axel Le Cesne; Ying Su; Julie Meade; Tao Wang; Matthew L Sherman; Rodrigo Ruiz-Soto; Michael C Heinrich